Zimmer Biomet price target lowered to $125 from $130 at RBC Capital
RBC Capital analyst Shagun Singh lowered the firm’s price target on Zimmer Biomet (ZBH) to $125 from $130 but keeps an Outperform rating on the ...
Zimmer Biomet price target lowered to $119 from $126 at Raymond James
Raymond James lowered the firm’s price target on Zimmer Biomet (ZBH) to $119 from $126 and keeps an Outperform rating on the shares. Zimmer ...
January Recap: 13 Top Health Press Releases
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 This proposed transaction further diversifies Zimm ...